Search Results - "Crouthamel, Matthew H"
-
1
Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate
Published in Circulation research (02-09-2011)“…Vascular calcification contributes to the high risk of cardiovascular mortality in chronic kidney disease (CKD) patients. Dysregulation of calcium (Ca) and…”
Get full text
Journal Article -
2
Phosphate uptake-independent signaling functions of the type III sodium-dependent phosphate transporter, PiT-1, in vascular smooth muscle cells
Published in Experimental cell research (10-04-2015)“…Vascular calcification (VC) is prevalent in chronic kidney disease and elevated serum inorganic phosphate (Pi) is a recognized risk factor. The type III…”
Get full text
Journal Article -
3
Transport properties of valsartan, sacubitril and its active metabolite (LBQ657) as determinants of disposition
Published in Xenobiotica (04-03-2018)“…1. The potential for drug-drug interactions of LCZ696 (a novel, crystalline complex comprising sacubitril and valsartan) was investigated in vitro. 2…”
Get full text
Journal Article -
4
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
Published in Kidney international (01-06-2013)“…Elevated fibroblast growth factor 23 (FGF23) is associated with cardiovascular disease in patients with chronic kidney disease. As a potential mediating…”
Get more information
Journal Article -
5
Sodium-Dependent Phosphate Cotransporters and Phosphate-Induced Calcification of Vascular Smooth Muscle Cells: Redundant Roles for PiT-1 and PiT-2
Published in Arteriosclerosis, thrombosis, and vascular biology (01-11-2013)“…OBJECTIVE—Elevated serum phosphate has emerged as a major risk factor for vascular calcification. The sodium-dependent phosphate cotransporter, PiT-1, was…”
Get full text
Journal Article -
6
Development and characterization of transgenic mouse models for conditional gene knockout in the blood–brain and blood-CSF barriers
Published in Transgenic research (01-02-2012)“…For many CNS acting drugs, penetration into the central nervous system (CNS) is limited by the blood-CNS-barriers. In an effort to quantitate the role of the…”
Get full text
Journal Article -
7
MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents
Published in Cancer chemotherapy and pharmacology (01-06-2009)“…Purpose P-glycoprotein (P-gp), encoded by MDR1 (or ABCB1), is important in anticancer drug delivery and resistance. We evaluated alterations in P-gp-mediated…”
Get full text
Journal Article -
8
A novel MDR1 G1199T variant alters drug resistance and efflux transport activity of P-glycoprotein in recombinant Hek cells
Published in Journal of pharmaceutical sciences (01-12-2006)“…The human multidrug resistance gene MDR1 encodes the protein product P-glycoprotein (P-gp). P-gp is an integral membrane protein which mediates ATP-dependent…”
Get more information
Journal Article -
9
A Novel MDR1 GT1292-3TG (Cys431Leu) Genetic Variation and Its Effect on P-glycoprotein Biologic Functions
Published in The AAPS journal (01-12-2010)“…P-glycoprotein (P-gp) is a membrane-bound transporter protein that is encoded by the human multidrug resistance gene MDR1 ( ABCB1 ). P-gp recognizes a wide…”
Get full text
Journal Article